您当前所在位置:首页 > 资讯信息 > 新品上市
CAS:2769141-82-2 SR-1114 化合物 SR-1114
发布时间:2024-04-24     作者:kx   分享到:

英文名称: SR-1114

产品描述 SR-1114, a first-in-class PROTAC ENL degrader, induces rapid CRBN-dependent ENL degradation with DC50 values of 150 nM in MV4;11 cells, 311 nM in MOLM-13 cells, and 1.65 μM in OCI/AML-2 cells [1].

MF: C39H42N8O11S

MW: 830.87

CAS: 2769141-82-2

密度:1.56±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

酸度系数(pKa):7.13±0.50(Predicted)

体外活性 Certainly, here is a revised version of the sentence:


'Ser nM TPP nM CUR (7)' is a chemical compound that exhibits specific activity, engaging in targeted interactions within a designated chemical or biological context. The notation encapsulates its unique structure and function.


(Note: The sentence provided was incomplete and lacked context. I've crafted a general revision that addresses a typical description of chemical compound activity while retaining the original elements in parentheses and brackets. If there was additional information or specific jargon intended to be included, please provide the full sentence or context for more accurate assistance.)

体内活性 Ser nM TPP nM CUR (4 mg/kg; i.v. once) exhibits improved renal tissue distribution through KIM-1-receptor-mediated endocytosis within renal tubular epithelial cells, and it enhances the renal function in mice with acute kidney injury (AKI) [1].

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

CAS:2769141-82-2	SR-1114	化合物 SR-1114

PROteolysis TArgeting Chimeras (PROTACs) 通过将靶蛋白和 E3 连接酶结合起来,从而“劫持”细胞的泛素-蛋白酶体系统(UPS)来实现蛋白质的降解。由于 PROTACs 只需具有高选择性地结合其靶标(而不是抑制靶蛋白的酶活性),目前有许多努力将先前无效的抑制剂分子改造为 PROTACs,用作下一代药物。

产地:西安

用途:科研

厂家:西安齐岳生物科技有限公司

温馨提示:仅用于科研!

相关产品: 

DT2216

C004019

ACBI1

RSS0680


库存查询
Baidu
map